Dylan Jovine claims the next big biotech takeover in 2020 will be a” Cut and Paste” company
by backoffice | March 21, 2020 11:59 pm
along the line of CRISPR[1]. There are 3 stocks that fit that category from CRSP. EDIT, and NTLA. Anyone have an idea which one he’s talking about? Thanks
Endnotes:
- CRISPR: https://www.stockgumshoe.com/tag/crispr/
Source URL: https://www.stockgumshoe.com/2020/03/microblog-dylan-jovine-claims-the-next-big-biotech-takeover-in-2020-will-be-a-cut-and-paste-company/
That ad has been running for a long time now, but it’s Editas… covered here most recently:
https://www.stockgumshoe.com/reviews/behind-the-markets/whats-this-living-software-business-from-dylan-jovine/
The email blast he’s been sending out this month for a cancer company treating lymphoma that “could save your life” is MEI Pharma (MEIP). It was not hard for me to figure out with the clues he gave, most notably, MEI received FDA fast track approval in early April and recently received a $100M investment from a foreign pharma.
A company called Cytodyn with interests in HIV has made recent forays into the Philippines with Monoclonal drug called Leronlimab…used on Ex-Pres Estrada…any information on the company beside it’s website.
There are pages and pages here, even an article or two. Search $CYDY Best!
Jovine is pushing EDIT again. I just received his pitch today 1/14/23. Act now and you’ll get his full report for just $39 an incredible “markdown” from his regular $199 price for the first 1000 subscribers. blah blah blah. It took me all of 5 minutes on the internet to confirm that he was pitching EDIT. Then I found that Travis was already on the scent. Interesting but I have stopped betting on instant fame and fortune stocks. Sometimes you just have to learn the hard way.